Insiders · REGN

REGN insider transactions

Regeneron Pharmaceuticals Inc. (REGN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

REGN insiders

Everyone who has filed a Form 4 or 5 at Regeneron Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Andrew J MurphyCo-Chief Scientific Officer-$42.3M
• Huda Y ZoghbiDirector-$13M
• George L SingDirector-$46M
• Christine A PoonDirector-$54M
• Christopher R. FenimoreEVP Finance CFO-$24M
• Joseph J LarosaEVP General Counsel and Secret-$22.6M
• Kathryn GuariniDirector-$1.02M
• Michael S BrownDirector-$29.6M
• Marion McCourtEVP Commercial-$31.9M
• Arthur F RyanDirector-$9.7M
• Jason PitofskySVP Controller-$2.39M
• Bonnie L BasslerDirector-$19.2M
• Craig B. ThompsonDirector
• David P SchenkeinDirector
• Joseph L GoldsteinDirector-$9.79M
• N Anthony ColesDirector-$19.4M
• George YancopoulosBd. Co-Chair, President & CSO, Director-$246M
• Leonard S SchleiferBd. Co-Chair, President & CEO, Director-$234M
• Daniel P Van PlewEVP & General Mgr, Industrial-$45.8M
• Neil StahlEVP Research and Development-$46.8M
• Robert E LandryEVP Finance CFO-$9.15M
• P Roy VagelosDirector-$26.5M
• Marc Tessier-LavigneDirector-$31.7M
• Regeneron Pharmaceuticals, Inc.10% owner

Recent Form 3, 4, and 5 filings for REGN

• 22h
  Co-Chief Scientific Officer Murphy Andrew J gifted 1,054 shares, decreasing direct ownership by 2% to 46,779 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 22h
  Director Zoghbi Huda Y exercised 7,439 shares at a strike of $380.95 and sold $7,219,274 worth of shares (7,439 units at $970.46) (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 1d
  Director Sing George L exercised 15,269 shares at a strike of $378.77 and sold $20,376,358 worth of shares (21,129 units at $964.38), decreasing direct ownership by 19% to 25,147 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 1d
  Director Poon Christine A exercised 7,830 shares at a strike of $376.69 and sold $7,587,958 worth of shares (7,830 units at $969.09) (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 1d
  EVP Finance CFO Fenimore Christopher R. exercised 6,000 shares at a strike of $381.92, covered exercise/tax liability with 4,243 shares and gifted 15 shares, increasing direct ownership by 9% to 21,726 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 1d
  EVP General Counsel and Secret Larosa Joseph J exercised 12,283 shares at a strike of $381.92, covered exercise/tax liability with 8,686 shares and sold $4,311,890 worth of shares (4,466 units at $965.49), decreasing direct ownership by 2% to 38,906 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 2d
  Director Guarini Kathryn exercised 400 shares at a strike of $719.37 and sold $360,000 worth of shares (400 units at $900.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 2d
  Director Brown Michael S exercised 1,929 shares at a strike of $725.89 and sold $1,687,875 worth of shares (1,929 units at $875.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 2d
  EVP Commercial Mccourt Marion sold $984,195 worth of shares (1,132 units at $869.43) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 10,871 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 21d
  Co-Chief Scientific Officer Murphy Andrew J sold $3,204,376 worth of shares (4,147 units at $772.70) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 63d
  EVP Commercial Mccourt Marion sold $2,002,458 worth of shares (2,346 units at $853.56) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 12,003 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 63d
  Director Guarini Kathryn exercised 400 shares at a strike of $719.37 and sold $340,000 worth of shares (400 units at $850.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 76d
  EVP General Counsel and Secret Larosa Joseph J exercised 12,282 shares at a strike of $381.92 and covered exercise/tax liability with 9,019 shares, increasing direct ownership by 10% to 36,373 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 77d
  EVP Finance CFO Fenimore Christopher R. exercised 6,283 shares at a strike of $381.92 and covered exercise/tax liability with 4,599 shares, increasing direct ownership by 9% to 19,984 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 85d
  Director Guarini Kathryn exercised 400 shares at a strike of $719.37 and sold $320,000 worth of shares (400 units at $800.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 85d
  Director Zoghbi Huda Y exercised 800 shares at a strike of $376.69 and sold $640,000 worth of shares (800 units at $800.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 121d
  Director Ryan Arthur F sold $130,030 worth of shares (200 units at $650.15) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 17,303 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 185d
  Director Ryan Arthur F sold $70,524 worth of shares (100 units at $705.24) as part of a pre-agreed trading plan, decreasing direct ownership by 0.57% to 17,503 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 216d
  SEC Form 4 filed by Ryan Arthur F

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 247d
  Director Ryan Arthur F sold $78,550 worth of shares (100 units at $785.50), decreasing direct ownership by 0.56% to 17,703 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 255d
  Director Zoghbi Huda Y exercised 1,638 shares at a strike of $376.69 and sold $1,279,812 worth of shares (1,638 units at $781.33) (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 267d
  SVP Controller Pitofsky Jason sold $1,585,058 worth of shares (2,036 units at $778.52) and exercised 1,000 shares at a strike of $492.00, decreasing direct ownership by 20% to 4,272 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 267d
  Director Ryan Arthur F sold $77,853 worth of shares (100 units at $778.53), decreasing direct ownership by 0.56% to 17,803 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 301d
  Director Bassler Bonnie L exercised 1,500 shares at a strike of $374.12 and sold $1,200,000 worth of shares (1,500 units at $800.00) (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Zoghbi Huda Y was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Thompson Craig B. was granted 155 shares, increasing direct ownership by 25% to 775 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Sing George L was granted 155 shares, increasing direct ownership by 0.50% to 31,007 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Guarini Kathryn was granted 155 shares, increasing direct ownership by 35% to 603 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Schenkein David P was granted 155 shares, increasing direct ownership by 35% to 603 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Goldstein Joseph L was granted 155 shares, increasing direct ownership by 2% to 6,703 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Ryan Arthur F was granted 155 shares, increasing direct ownership by 0.87% to 17,903 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Coles N Anthony was granted 155 shares, increasing direct ownership by 10% to 1,714 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Brown Michael S was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Bassler Bonnie L was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 303d
  Director Poon Christine A was granted 155 shares, increasing direct ownership by 3% to 5,219 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 304d
  Bd. Co-Chair, President & CSO Yancopoulos George converted options into 28,570 shares and covered exercise/tax liability with 28,570 shares (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 304d
  Bd. Co-Chair, President & CEO Schleifer Leonard S converted options into 28,570 shares and covered exercise/tax liability with 28,570 shares (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 309d
  Director Sing George L exercised 9,212 shares at a strike of $520.01 and covered exercise/tax liability with 6,188 shares, increasing direct ownership by 11% to 30,852 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 329d
  EVP & General Mgr, Industrial Van Plew Daniel P covered exercise/tax liability with 2,552 shares, decreasing direct ownership by 11% to 21,673 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 329d
  EVP Research Murphy Andrew J covered exercise/tax liability with 4,229 shares, decreasing direct ownership by 8% to 47,833 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 329d
  EVP Commercial Mccourt Marion covered exercise/tax liability with 1,021 shares, decreasing direct ownership by 7% to 14,349 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 329d
  Bd. Co-Chair, President & CSO Yancopoulos George exercised 146,815 shares at a strike of $555.67 and covered exercise/tax liability with 131,874 shares, increasing direct ownership by 5% to 310,460 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 329d
  Bd. Co-Chair, President & CEO Schleifer Leonard S covered exercise/tax liability with 155,145 shares and exercised 172,723 shares at a strike of $555.67, increasing direct ownership by 9% to 214,523 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  VP Controller Pitofsky Jason covered exercise/tax liability with 989 shares and was granted 2,064 shares, increasing direct ownership by 25% to 5,308 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  EVP & General Mgr, Industrial Van Plew Daniel P was granted 3,715 shares and covered exercise/tax liability with 1,906 shares, increasing direct ownership by 8% to 24,225 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  EVP Research Murphy Andrew J was granted 3,715 shares and covered exercise/tax liability with 1,699 shares, increasing direct ownership by 4% to 52,062 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  EVP Commercial Mccourt Marion was granted 2,476 shares and covered exercise/tax liability with 1,336 shares, increasing direct ownership by 8% to 15,370 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  EVP General Counsel and Secret Larosa Joseph J covered exercise/tax liability with 1,396 shares and was granted 2,476 shares, increasing direct ownership by 4% to 29,517 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 331d
  EVP Finance CFO Fenimore Christopher R. covered exercise/tax liability with 992 shares and was granted 3,027 shares, increasing direct ownership by 13% to 18,300 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 346d
  EVP General Counsel and Secret Larosa Joseph J exercised 14,450 shares at a strike of $555.67 and covered exercise/tax liability with 12,686 shares, increasing direct ownership by 8% to 22,839 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 346d
  Director Bassler Bonnie L sold $570,000 worth of shares (760 units at $750.00) and exercised 760 shares at a strike of $371.40 (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 360d
  VP Controller Pitofsky Jason sold $280,766 worth of shares (431 units at $651.43), decreasing direct ownership by 9% to 4,233 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 370d
  Director Poon Christine A exercised 9,212 shares at a strike of $520.01 and sold $4,252,745 worth of shares (6,500 units at $654.27), increasing direct ownership by 115% to 5,064 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 370d
  EVP Research Murphy Andrew J exercised 35,000 shares at a strike of $555.67, covered exercise/tax liability with 32,490 shares and gifted 1,538 shares, increasing direct ownership by 2% to 50,046 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Schenkein David P was granted 166 shares, increasing direct ownership by 59% to 448 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Thompson Craig B. was granted 166 shares, increasing direct ownership by 37% to 620 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Coles N Anthony was granted 166 shares, increasing direct ownership by 12% to 1,559 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Zoghbi Huda Y was granted 166 shares, increasing direct ownership by 12% to 1,548 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Ryan Arthur F was granted 166 shares, increasing direct ownership by 0.94% to 17,748 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
• 668d
  Director Poon Christine A transferred by will 14 shares) and was granted 166 shares, increasing direct ownership by 8% to 2,352 units (SEC Form 4)

  4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)